Biotech Spain

Asphalion signs the Manifesto for EU COVID-19 Research

Drug development, Medical Devices, Communication & Media, Biodrugs, Clinical trials, Epidemiology, Manufacture of biotech equipment, Infections, Scientific & Technical instruments, Sales & Marketing

The European Commission has launched a Manifesto to maximise the accessibility of research results in the fight against COVID-19 and Asphalion has signed it to reinforce its commitment to bring solutions and alternatives to fight this pandemic situation.

Since the beginning of the COVID-19 crisis, Asphalion has always offered all its expertise in Regulatory Affairs by:

  • Participating in clinical trials related to potential COVID-19 treatments.
  • Providing advice and guidance at clinical, technical and procedural levels to facilitate the availability and authorisation of medical devices and personal protection equipment as soon as possible.
  • Participating in research projects in the extraordinary COVID-19 call done by the EU through Horizon 2020.

We would like to keep supporting in whatever is needed at this time so do not hesitate to contact us if you need help: covid19@asphalion.com

Fuente: Asphalion

https://www.asphalion.com/news/asphalion-signs-the-manifesto-for-eu-covid-19-research/
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream

Tags

About us

Biotechnology portal in Spain

Monthly Newsletter

Subscribe to our newsletter and stay up to date with the latest news and deals!

Contact us

Biotech Spain
Biotech-Spain.com - Site Developments SL
Avenida Diagonal 399, 1ª planta
Barcelona, Barcelona 08008
P: +34 606 96 07 82 ( Urgencias )

2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy

Articles

Substance abuse Agrobiotechnology Food - Substance detection Animal food - Feed Functional food Analgesia & pain Associations Biobanks Bioclusters Biofuels Biodrugs Bioinformatics Cellular and molecular biology Systems biology Evolutionary biology Synthetic biology Biomarkers Biomaterials Marine-based biotechnology Business Angels Cancer Stem cells Cardiovascular and circulatory system Research Centers Private clinic Communication & Media Consultancy Biologic control (plagues...) Quality control Corporate investor Cosmetics Cell culture GM Crops Biological defense Dental Dermatology Muskuloskeletal disorders Biotechnology kits Software development Diagnostic - Imaging Medical Devices Drug Delivery Drug development Drug discovery Pregnancy, reproduction Venture capital management company Energy Bone diseases Chronic diseases Degenerative diseases Genetic diseases Hereditary diseases Inflamatory diseases Neurologic Diseases Rares diseases Clinical trials Public entity Epidemiology Epigenetics Medical and surgical equipment Patient monitoring equipment Manufacture of biotech equipment Manufacter of resins to purification Manufacture and commercialization of fermentation or biocatalysis Manufacture and commercialization of enzymes Manufacture and commercialization of cell lines Manufacture and commercialization microorganism Manufacture of APIs and chemical products from renewable raw material Manufacture of monomers and polymers Pharmacy Pharmacogenomics Public financing Investment Funds Training Foundatio Foundation Genomics Hospitals Infections Engineering Immunology Healthcare facilities and services Scientific & Technical instruments Internet and information technologies Institutional investor Private investor Leasing Environmental cleanup - testing Maintenance cell cultures Sales & Marketing Environment Metabolomics Microbiology Nanotechnology Neuroscience Nutrition Oftalmology Cost optimization Other enhancement techniques (molecular marker..) Peptides Science - Technology parks Probiotics Blood products Disposable medical products Industrial property, patents & trademarks Proteins Proteomics DNA tests Diagnostic tests Scientific publications Chemistry Human Resources Research network Residues revaloration and bioremed Animal health Women's health Child health Mental health Senior health Healthy Blood and lymphatic system Screening Food Safety CRO - CMO Services Research services and supplies Legal services Auditory system Digestive system Kidney and genitourinary system Locomotive system Metabolic system - endocrinology Central Nervous System Respiratory and pulmonary system Laser Optical Systems Cellular Therapy Gene Therapy Tissue therapy Toxicology Technology transfer Transplant Universities Vaccines Venture capital Vitamins and nutrition products Viral vector

Directory

Substance abuse Agrobiotechnology Food - Substance detection Animal food - Feed Functional food Analgesia & pain Associations Biobanks Bioclusters Biofuels Biodrugs Bioinformatics Cellular and molecular biology Systems biology Evolutionary biology Synthetic biology Biomarkers Biomaterials Marine-based biotechnology Business Angels Cancer Stem cells Cardiovascular and circulatory system Research Centers Private clinic Communication & Media Consultancy Biologic control (plagues...) Quality control Corporate investor Cosmetics Cell culture GM Crops Biological defense Dental Dermatology Muskuloskeletal disorders Biotechnology kits Software development Diagnostic - Imaging Medical Devices Drug Delivery Drug development Drug discovery Pregnancy, reproduction Venture capital management company Energy Bone diseases Chronic diseases Degenerative diseases Genetic diseases Hereditary diseases Inflamatory diseases Neurologic Diseases Rares diseases Clinical trials Public entity Epidemiology Epigenetics Medical and surgical equipment Patient monitoring equipment Manufacture of biotech equipment Manufacter of resins to purification Manufacture and commercialization of fermentation or biocatalysis Manufacture and commercialization of enzymes Manufacture and commercialization of cell lines Manufacture and commercialization microorganism Manufacture of APIs and chemical products from renewable raw material Manufacture of monomers and polymers Pharmacy Pharmacogenomics Public financing Investment Funds Training Foundatio Foundation Genomics Hospitals Infections Engineering Immunology Healthcare facilities and services Scientific & Technical instruments Internet and information technologies Institutional investor Private investor Leasing Environmental cleanup - testing Maintenance cell cultures Sales & Marketing Environment Metabolomics Microbiology Nanotechnology Neuroscience Nutrition Oftalmology Cost optimization Other enhancement techniques (molecular marker..) Peptides Science - Technology parks Probiotics Blood products Disposable medical products Industrial property, patents & trademarks Proteins Proteomics DNA tests Diagnostic tests Scientific publications Chemistry Human Resources Research network Residues revaloration and bioremed Animal health Women's health Child health Mental health Senior health Healthy Blood and lymphatic system Screening Food Safety CRO - CMO Services Research services and supplies Legal services Auditory system Digestive system Kidney and genitourinary system Locomotive system Metabolic system - endocrinology Central Nervous System Respiratory and pulmonary system Laser Optical Systems Cellular Therapy Gene Therapy Tissue therapy Toxicology Technology transfer Transplant Universities Vaccines Venture capital Vitamins and nutrition products Viral vector